Basit öğe kaydını göster

dc.contributor.authorZULFIKAR, B
dc.contributor.authorGEDIKOGLU, G
dc.date.accessioned2021-03-06T20:57:23Z
dc.date.available2021-03-06T20:57:23Z
dc.date.issued1992
dc.identifier.citationZULFIKAR B., GEDIKOGLU G., "EWINGS-SARCOMA - EXPERIENCE WITH 12 CASES", JOURNAL OF CHEMOTHERAPY, cilt.4, ss.50-55, 1992
dc.identifier.issn1120-009X
dc.identifier.otherav_fc8fd6f4-b36b-4bed-bde7-5e9a4dad2f46
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/165282
dc.identifier.urihttps://doi.org/10.1080/1120009x.1992.11739139
dc.description.abstractTwelve patients with localized Ewing's sarcoma were treated between 1980-1990 at the Istanbul School of Medicine, Department of Pediatric Oncology-Hematology, Oncology Research and Treatment Center and Our Children Leukemia Foundation. There were 8 boys and 4 girls, with a mean age of 8.1 (range 3-17) years. The tumors were in the femur in 3 patients, in the humerus and rib in 2 patients each and in the tibia, radius, vertebra, clavicula and pelvis in 1 patient each. Chemotherapy alone was applied in 2 patients, 1 patient had chemotherapy and radiotherapy. The remaining 9 cases were treated with Chemotherapy and radiotherapy (during the chemotherapy). The chemotherapy protocols were: VAC (n = 5), VACA (n = 3), IVAD (n = 3) and T.9 (n = 1). One patient died from the disease itself. Remissions were achieved in the other 11 patients. After 5 to 95 months (mean: 22 months) 7 patients had relapsed (4 had local and 3 had distant metastases). Three patients were not able to be followed, 3 died due to additional problems (infection, cardiotoxicity). The best prognosis was achieved when Ewing's sarcoma initiated in the long bones, with less than 100 ml tumor volumes and patients were under 5 years old. There were no significant differences among chemotherapy protocols.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectGeneral Immunology and Microbiology
dc.subjectPharmacology
dc.subjectImmunology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectHistology
dc.subjectPathology and Forensic Medicine
dc.subjectOncology
dc.subjectBiochemistry (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectInfectious Diseases
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectPharmacology (medical)
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectPATOLOJİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.titleEWINGS-SARCOMA - EXPERIENCE WITH 12 CASES
dc.typeMakale
dc.relation.journalJOURNAL OF CHEMOTHERAPY
dc.contributor.departmentİstanbul Üniversitesi , Onkoloji Enstitüsü , Teşhis Tedavi Ve Bakım Hizmetleri
dc.identifier.volume4
dc.identifier.issue1
dc.identifier.startpage50
dc.identifier.endpage55
dc.contributor.firstauthorID113280


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster